Target intelligence / Profile preview

Multiple cell types at injured digestive tract tissue

Molecular classification
Other
01

Overview

Multiple cell types at injured digestive tract tissue refers to the heterogeneous cellular environment found at sites of mucosal damage, including epithelial cells, myofibroblasts, and various immune cells (Source: Nature Reviews Gastroenterology & Hepatology, 2021). This context is critical in conditions like Inflammatory Bowel Disease (IBD), where the failure of these cells to coordinate repair leads to chronic ulceration (Source: StatPearls, 2023). While not a single molecular target, this environment is the site of action for therapies aiming to promote mucosal healing, a key clinical endpoint in gastroenterology (Source: Gastroenterology & Hepatology, 2019). Drugs or cell therapies targeting this area often focus on restoring the epithelial barrier or modulating the local inflammatory cytokine environment (Source: Frontiers in Immunology, 2022). Because it represents a physiological location and a collection of diverse biological entities rather than a specific protein or gene, it is classified as an incorrect or non-specific target designation for drug discovery purposes.

Other names
Injured gastrointestinal mucosaGastrointestinal wound microenvironmentDamaged digestive tract tissue
02

Mechanism of action

Not applicable as this refers to a tissue microenvironment rather than a specific molecular target.

03

Biological functions

Tissue repairWound healingInflammationEpithelial barrier restoration
04

Disease associations

Inflammatory bowel diseasePeptic ulcer diseaseGastritisRadiation enteritis
05

Safety considerations

Non-specific systemic effectsRisk of fibrosis or scarring during repairDifficulty in localized drug delivery
06

Biomarkers

Fecal calprotectinC-reactive proteinEndoscopic mucosal healing scores

Beyond the preview

Go deeper on Multiple cell types at injured digestive tract tissue.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Multiple cell types at injured digestive tract tissue.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call